In pregnant women with type 1 diabetes mellitus. Higher Cord Blood Levels of Fatty Acids in Pregnant Women With Type 1 Diabetes Mellitus
|
|
- Gilbert Bryant
- 5 years ago
- Views:
Transcription
1 CLINICAL RESEARCH ARTICLE Higher Cord Blood Levels of Fatty Acids in Pregnant Women With Type 1 Diabetes Mellitus Josip Djelmis, 1 Marina Ivanišević, 1 Gernot Desoye, 2 Mireille van Poppel, 3 Edina Berberović, 4 Dragan Soldo, 5 and Slavko Oreskovic 1 1 Referral Center for Diabetes in Pregnancy, Ministry of Health Republic of Croatia, Clinical Department of Obstetrics and Gynecology, Zagreb University Hospital Center, School of Medicine, University of Zagreb, HR Zagreb, Croatia; 2 Department of Obstetrics and Gynecology, Medical University of Graz, A-8036 Graz, Austria; 3 Institute of Sport Science, University of Graz, A-8036 Graz, Austria; 4 Clinical Department of Obstetrics and Gynecology, Holy Spirit University Hospital, HR Zagreb, Croatia; and 5 Department of Obstetrics and Gynecology, Mostar Clinical Hospital Center, School of Medicine, University of Mostar, BIH Mostar, Bosnia and Herzegovina Context: Type 1 diabetes mellitus (T1DM) is associated with a disturbance of carbohydrate and lipid metabolism. Objective: To determine whether T1DM alters maternal and neonatal fatty acid (FA) levels. Design: Observational study. Setting: Academic hospital. Patients: Sixty pregnant women (30 women with T1DM with good glycemic control and 30 healthy women) were included in the study. Maternal blood, umbilical vein, and artery blood samples were collected immediately upon delivery. Following lipid extraction, the FA profiles of the total FA pool of maternal serum and umbilical vein and artery serum were determined by gas chromatography. Results: Total FA concentration in maternal serum did not differ between the study groups; it was significantly higher in umbilical vein serum of the T1DM group compared with that in the control group [median (interquartile range)]: T1DM ( to ) and control (657.5 to ; P, 0.001), and in umbilical artery vein serum: T1DM ( to ) and control (643.3 to ; P, 0.001). Composition of FAs in umbilical vein serum showed significantly higher concentrations of saturated, monounsaturated, and polyunsaturated FAs (SFAs, MUFAs, and PUFAs, respectively) in the T1DM group than compared with those in the control group (P = 0.001). Furthermore, cord blood levels of leptin (P, 0.001), C-peptide (P, 0.001), and insulin resistance (P = 0.015) were higher in the T1DM group compared with controls. Conclusion: The neonates born to mothers with T1DM had higher concentrations of total FAs, SFAs and MUFAs, as well as PUFAs, compared with control newborns. (J Clin Endocrinol Metab 103: , 2018) In pregnant women with type 1 diabetes mellitus (T1DM), endogenous insulin production is absent or minimal, thus requiring exogenous insulin for glycemic control and prevention of ketoacidosis (1). In addition to disturbances of carbohydrate metabolism, T1DM is associated with changes in the content and composition of maternal lipids (2). Whether T1DM also influences content and composition of fetal lipids in the umbilical circulation is currently unknown. ISSN Print X ISSN Online Printed in USA Copyright 2018 Endocrine Society Received 2 February Accepted 25 April First Published Online 1 May 2018 Abbreviations: AA, arachidonic acid; BMI, body mass index; CS, Caesarean section; DHA, docosahexaenoic acid; EPA, eicosapentaenoic acid; FA, fatty acid; GDM, gestational diabetes; HOMA, homeostasis model assessment; LC-PUFA, long-chain polyunsaturated fatty acid; MUFA, monounsaturated fatty acid; PUFA, polyunsaturated fatty acid; r, Pearson correlation coefficient; rs, Spearman correlation coefficient; SFA, saturated fatty acid; T1/2DM, type 1/2 diabetes mellitus J Clin Endocrinol Metab, July 2018, 103(7): doi: /jc
2 doi: /jc Maternal sources of fetal lipids include lipoproteinassociated triacylglycerols, phospholipids, and cholesterol esters, as well as free fatty acids (FAs). The current understanding of maternal lipid supply for the fetus involves the transfer of free FAs and free cholesterol, after which, both moieties are esterified in the fetal liver and packaged into lipoproteins (2). Despite the presence of FA transporters in the syncytiotrophoblast (3), free FAs are likely to cross this membrane by diffusion (4, 5). Nonessential FAs can also be formed de novo from carbohydrates and acetate in the fetus under the control of fetal insulin (6, 7). In normal circumstances, free FAs have a minor role in energy provision; however, they generally can serve as energy deposits in the neonatal period (6). Particularly important for the fetus are the essential FAs, i.e., long-chain polyunsaturated FA (LC-PUFAs) (8). One of those LC-PUFAs, docosahexaenoic acid (DHA), has a major role in the development of nervous system cells, and its cord blood concentrations are associated with psychomotor development at 6 months of age (9, 10). In pregnant women, there is an increased maternalfetal transfer of essential over nonessential FAs (11, 12). The aim of the study was to investigate the impact of T1DM on materno-fetal levels of FAs. Specifically, we tested the hypothesis of whether T1DM alters the FA profiles of maternal blood, the umbilical vein, and artery blood. Materials and Methods Study population This prospective study included a total of 60 pregnant women with singleton pregnancies who had either T1DM (T1DM group, n = 30) or were healthy (control group, n = 30). Pregnant women with T1DM were followed up at the Department of Obstetrics and Gynecology, Zagreb University Hospital Center, from 2012 to Study women had a T1DM duration of 5 to 10 years, were without diabetes complications, had a normal course of pregnancy, and delivered healthy, eutrophic newborns within the 25th to 75th birthweight percentile, according to weeks of pregnancy, sex, and parity (13). Pregnant women with T1DM were on intensified insulin analogs therapy and had well-controlled glycemia. Healthy women underwent gestational diabetes (GDM) screening, according to International Association of Diabetes and Pregnancy Study Groups criteria, with 75 g oral glucose tolerance test between gestational weeks 24 and 34 (14). Women with preterm delivery, multiple pregnancies, diabetic complications (retinopathy, nephropathy, neuropathy, and chronic hypertension), fetal chromosomal anomalies, or malformations were excluded from the study. Additional exclusion criteria were smoking by self-report, n-3 and n-6 FA supplementation, gestational hypertension/pre-eclampsia, and GDM. Gestational age was determined by the first day of last menstruation and verified by ultrasound examination between 6 and 10 weeks of gestation. All pregnancies were terminated by elective Caesarean section (CS) between gestational weeks 39 and 40. The mothers fasted for at least 10 hours before the CS. Maternal blood glucose during delivery was maintained in the range of 4 to 5 mm by IV infusion of 500 ml 5% glucose with insulin. Pregnancies in mothers with T1DM were terminated by CS as a standard procedure, whereas in the control group, indications for CS were breach presentation, narrow pelvis, post-cs state, or CS on mother s demand. Maternal venous blood samples (5 ml) were collected during delivery. Umbilical cord blood was obtained during the CS, immediately after delivery but before the placenta was removed through puncture of the umbilical vessels. Blood was centrifuged immediately after collection, and the sera were stored at 280 C until analysis. C-Peptide and leptin concentrations and HbA 1c percentage were determined in maternal and umbilical vein serum. Free FA concentrations were quantified in maternal and umbilical vein and arterial serum. Ethical statement The study was approved by the Ethics Committee of the Clinical Department of Obstetrics and Gynecology, Zagreb University Hospital Center, School of Medicine, University of Zagreb (No /117A-2012). All women included in the study provided written, informed consent for themselves and their newborns. Data collection The following parameters were recorded: maternal height (centimeters) and weight (kilograms) measured before pregnancy; gestational weight gain as the difference between weight before pregnancy (self-reported) and at time of delivery; and prepregnancy body mass index (BMI; kilograms per square meter; BMI), calculated from prepregnancy values. Maternal HbA 1c was determined in each trimester in the T1DM group and between the 36th and 38th weeks of pregnancy in the control group. Neonatal birth weight (grams), birth length (centimeters), and 1 and 5 minute Apgar scores were measured. Blood sample analyses FA quantification Total lipids were extracted by a mixture of chloroform/ methanol solvent, a method of increasing polarity, according to Folch et al. (15). Heptadecanoic acid (C17:0) was used as the internal standard. FAs from lipid extracts were converted to methyl esters by trans-esterification with methanolic HCl (International Organization for Standardization standard). The FA profile was determined by gas chromatography-mass spectrometry on a Varian 3400 (Varian, Palo Alto, CA), equipped with a Saturn II ion trap mass spectrometer operating in the electron impact mode, as previously described (12). The concentration of each FA (micrograms per milliliter) was quantified by comparing the area of the internal standard peak (C17:0) with the peak area surface of a single FA. The results are expressed as percent (micrograms per 100 mg FAs) of arachidonic acid (AA) and DHA. Glucose, HbA 1c, C-peptide, and leptin quantification Glucose levels were quantified by the hexokinase method on a Cobas C301 analyzer, and HbA 1c levels in whole blood
3 2622 Djelmis et al T1DM Alters Neonatal Fatty Acids J Clin Endocrinol Metab, July 2018, 103(7): were measured by the Turbidimetric Inhibition Immunoassay on a Cobas C501 analyzer with reagents from the manufacturer (Roche, Basel, Switzerland). C-peptide concentration was determined by ELISA (C-peptide ELISA; Mercodia, Uppsala, Sweden). Serum leptin concentration was determined by ELISA (Quantikine Human Leptin Immunoassay; R&D Systems, Minneapolis, MN). Neonatal insulin resistance was calculated according to homeostasis model assessment 2 (HOMA2) (16), using software available online ( Statistical analysis Statistical analyses were performed with SPSS statistical package (release by SPSS version 24 software; IBM, Chicago, IL). Continuous variables are expressed as the means 6 SD or medians (25th to 75th percentile) for a skewed distribution, and qualitative variables are presented as frequencies and percentages. Between-group differences in normally distributed continuous variables were assessed with a t test. The Mann-Whitney U test was used for variables with a skewed distribution, and a x 2 -test was used for proportions. For repeated measurements of continuous data, the Wilcoxon signed-rank test was used. Pearson correlation coefficient (r) was used to assess linear dependence between normally distributed variables. Linear regression was performed between the concentration of total FAs in maternal and umbilical vein serum and between docosahexaenoic and arachidonic FAs. Data that were not normally distributed were log transformed before analyses. Regression with Spearman correlation coefficient (rs) was performed for non-normality data. Statistical tests were two sided. Statistical analyses were considered significant when P, Results Maternal and neonatal characteristics Women with T1DM and controls did not differ (P. 0.05) in maternal age, BMI, or gestational weight gain (Table 1). Neonates did not differ in gestational age at delivery, neonatal birth weight, or Apgar scores at 1 and 5 minutes. Neonates born to mothers with T1DM were shorter (P = 0.001) and thus, had a higher ponderal index (P, 0.001) compared with control group neonates. The HbA 1c values in the T1DM group dropped from 6.6% to 5.9% from the first to the third trimester (P = 0.022) but were still higher (P, 0.001) than in the control group (4.8%; Table 1). Glucose, C-peptide, leptin, glucose levels, and insulin resistance in maternal and neonatal blood Maternal C-peptide concentration was higher (P = 0.007) in the control group than in the T1DM group (Table 1). Women with T1DM had median C-peptide levels of (interquartile range (94 to 554.8) pm, indicating that their b-cell function and endogenous Table 1. Maternal and Neonatal Characteristics T1DM (n = 30) Control (n = 30) P Maternal characteristics Age, y Prepregnancy BMI, kg/m Gestational weight gain, kg HbA 1C first trimester, % a NA HbA 1C second trimester, % NA HbA 1C third trimester, % a Gestational age at delivery, wk Maternal serum measurements C-Peptide, pm ( ) ( ) Glucose, mm 4.0 ( ) 3.5 ( ) Leptin, ng/ml 25.0 ( ) 19.7 ( ) Neonatal characteristics Birth weight, g Birth length, cm Ponderal index, g, 3 100/(cm) ( ) 2.6 ( ) <0.001 Apgar score at 1 min Apgar score at 5 min Sex ratio: male/female, n (%) b 14/16 (46.7/53.3) 20/10 (66.7/33.3) Umbilical vein blood measurements C-Peptide, pm ( ) ( ) <0.001 Insulin resistance HOMA2 1.5 ( ) 0.7 ( ) Glucose, mm 3.2 ( ) 2.9 ( ) Leptin, ng/ml 15.8 ( ) 6.8 ( ) <0.001 Data are means (SD) unless otherwise indicated; data are median (first and third quartiles); t test was used to test statistical difference between two groups or Mann-Whitney U test. P values in bold are significant. Abbreviation: NA, not available. a Wilcoxon signed-rank test; HbA 1c between first and third trimester in T1DM; P = b The x 2 test was used on group comparison.
4 doi: /jc insulin production were, in part, preserved. Maternal plasma glucose and leptin concentrations were similar in both groups. In the neonates, the umbilical cord vein concentrations of C-peptide (P, 0.001) and leptin (P, 0.001), as well as HOMA2 insulin resistance (P = 0.015), were higher in the T1DM group, whereas plasma glucose concentrations were similar in both groups (Table 1). FAs in maternal serum The total FA concentration in serum of women with T1DM did not differ significantly (P = 0.074) when compared with the control group (Table 2). Although the concentration of saturated FAs (SFAs) in mothers with T1DM was not significantly different from controls (P = 0.071), the percentage of SFAs was significantly lower in T1DM than in the control group (34.8% vs 37.6%, P = 0.006). The concentration of both monounsaturated FAs (MUFAs) and PUFAs was significantly higher in serum of women with T1DM compared with controls (P = and P = 0.027,respectively). However, the percentage of MUFAs and PUFAs was not significantly different between the groups (Table 2). FAs in umbilical vein serum In umbilical vein serum, the concentration of total FAs, SFAs, MUFAs, and PUFAs was higher in T1DM compared with controls (Table 2). The percentage of SFAs in umbilical vein was lower in the T1DM group (34.9% vs 44.3%, P = 0.002). In contrast, the percentage of MUFAs was higher in T1DM (31.9% vs 19.9%, P = 0.002), whereas the percentage of PUFAs did not differ (32.8% vs 31.4%, P = 0.53; Table 2). FAs in umbilical artery serum In umbilical artery serum, the concentration of total FAs, MUFAs, and PUFAs was higher in T1DM when compared with the controls (Table 2). Compared with controls, the concentration of SFAs and the percentage of SFAs were lower in T1DM (201.8 vs 229.9, P ; 34.7% vs 44.0%, P, 0.001). The percentage of MUFAs did not differ between the two groups, whereas the percentage of PUFAs was higher in T1DM than in the control group (31.3% vs 28.8%, P = 0.008). Comparisons of FAs between maternal and umbilical vein serum The concentrations of total FAs, SFAs, MUFAs, and PUFAs were higher in maternal serum of both T1DM and control women when compared the corresponding umbilical vein serum (all P, 0.001; Table 2). In controls, maternal serum was less rich in SFAs compared with umbilical vein serum (37.6% vs 44.3%, P = 0.004), but this difference was not found in T1DM (34.8% vs 34.9%, P = 0.230). A lower percentage of MUFAs was found in maternal serum of T1DM (21.3% vs 31.9%) when compared with umbilical vein serum (P, 0.001), whereas in the control group, the percentage MUFAs was higher in maternal (20.3%) than in umbilical vein serum (19.9%, P, 0.001). A higher percentage of PUFAs was found in maternal serum than in umbilical vein serum in both groups (T1DM: 43.3% vs 32.8%; controls: 41.7% vs 31.4%). Comparisons of FAs between umbilical vein and artery serum In T1DM, the concentrations of total FAs, SFAs, MUFAs, and PUFAs were all significantly higher in umbilical vein compared with the corresponding umbilical artery serum, but the percentages were not different (Table 2). In controls, total FA concentration was higher in umbilical vein serum compared with artery serum. No differences in the concentration of SFAs and MUFAs were found between umbilical vein and artery serum of controls. The PUFA concentration was lower in umbilical vein than in artery serum. The percentage of SFAs was not different between venous and arterial serum in controls, whereas the percentage of MUFAs and PUFAs was lower and higher, respectively, in umbilical vein than in artery serum. FA profile in maternal, umbilical vein, and umbilical artery serum In maternal vein serum, the concentrations of all particular FAs tended to be higher in T1DM, but only the concentrations of oleic (C18:1n-9), DHA (C22:6n-3), and linoleic acid (C18:3n-6) were significantly different from controls (Table 3). In the umbilical vein serum, the concentrations of all particular FAs, except myristic acid (C14:0), were significantly higher in the T1DM group compared with the control group. In the umbilical artery serum, differences between T1DM and controls were smaller, and only concentrations for palmitoleic (C16:1n-7), oleic (C18:1n-9), linoleic acid (C18:3n-6), and AA (C20:4n-6) were higher in the T1DM group compared with the control group. The FA concentrations not higher in T1DM were palmitic acid (C16:0) and stearic acid (C18:0) in umbilical artery serum, and in addition, the percentage DHA was significantly lower in T1DM compared with controls (2.7% vs 3.4%, P = 0.02). Correlation between maternal serum and umbilical vein serum of total FAs and among neonatal ponderal index, glucose, and insulin resistance (HOMA2) Maternal and umbilical vein total FAs were correlated with Pearson correlation coefficient (r)(r = 0.685; P, 0.001;
5 2624 Djelmis et al T1DM Alters Neonatal Fatty Acids J Clin Endocrinol Metab, July 2018, 103(7): Table 2. Concentration of Total, SFA, MUFA, and PUFA and Percent of FAs (micrograms per 100 mg FAs) in Maternal and Umbilical Vein and Artery Blood Maternal Serum FAs T1DM (n = 30) Control (n = 30) P Total FAs, mg/ml ( ) a ( ) b SFAs, mg/ml ( ) e ( ) f Percent SFAs, mg/100 mg FA 34.8 ( ) i 37.6 ( ) j MUFAs, mg/ml ( ) m ( ) n Percent MUFAs, mg/100 mg FA 21.3 ( ) q 20.3 ( ) r PUFAs (n-3 + n-6 FAs), mg/ml ( ) u ( ) v Percent of PUFA (n-3 + n-6 FAs), mg/100 mg FA 43.3 ( ) y 41.7 ( ) z (Continued) Fig. 1). Umbilical artery and umbilical vein total FAs were strongly correlated (rs = 0.883; P, 0.001). Maternal glucose concentrations were strongly correlated with glucose in umbilical vein (rs = 0.763; P, 0.001; (Table 4). Longer-term, higher maternal glucose levels, reflected in higher HbA 1c (percentage) levels, were correlated with neonatal ponderal index (rs = 0.507; P = 0.003). Ponderal index was positively correlated with both leptin (rs = 0.263; P = 0.043) and insulin resistance (HOMA2; rs = 0.526; P = 0.005) in umbilical cord blood. Both C-peptide (rs = 0.379; P = 0.003) and insulin resistance (HOMA2; rs = 0.456; P = 0.02) in umbilical cord blood were correlated to total FAs in umbilical artery serum. Discussion The current study compared FA concentrations and the FA profile in maternal and umbilical venous and arterial serum between well-controlled T1DM and control mothers. Adiposity, which is a confounder of lipid and FAs levels, was comparable in the mothers, as there was no between-group difference in BMI and gestational weight gain. Similar to other studies (17), also, leptin levels did not differ between the two study groups. The most important finding was that well-controlled T1DM affects the FA levels, mostly in the neonates, in which the levels of total FAs, as well as most of the SFAs, MUFAs and PUFAs, were elevated compared with healthy controls. Importantly, also, the cord blood concentrations of the essential FAs, and in particular of DHA, were higher in the T1DM neonates than in the controls. Total FA concentrations were not significantly different between pregnant T1DM with good metabolic control and healthy, nondiabetic women. Large variation in the data may have precluded significance, as the concentrations of some FAs and FA classes were significantly elevated in maternal serum in the women with T1DM compared with control women. Consistent with the present results, also in GDM pregnancies, maternal lipids did not differ from control pregnancies (18). T1DM effects on neonatal anthropometrics and hormones The cord blood levels of C-peptide, leptin, and insulin resistance were also significantly higher in the T1DM group compared with the control group. T1DM, similar to GDM and T2DM, is a known factor that predisposes women to have hypertrophic newborns through an enhanced fetal glucose-insulin axis. This eventually leads to more fetal adipose tissue, as reflected by higher leptin levels (19, 20). Although the placenta also produces leptin, almost all leptin is released into the maternal circulation (21), thus making its contribution to the circulating leptin pool in the fetus small. Insulin and leptin in the cord blood are correlated, especially in neonates in the highest birthweight category (22). Leptin increases with the amount of adipose tissue and regulates fetal weight. Hence, children born to diabetic mothers have higher cord blood leptin levels than those born to nondiabetic mothers. Our leptin results are consistent with previous studies (23). Although we have not directly measured neonatal fat mass or relative body fat, the positive correlation (rs = 0.263; P = 0.043) between leptin and ponderal index may suggest an increase in neonatal fat in the T1DM pregnancies. The higher insulin resistance HOMA2 (P = 0.015) in neonates born to mothers with T1DM compared with control mothers is an important finding. Insulin resistance (HOMA2) correlated with the neonatal ponderal index. The higher insulin resistance in T1DM neonates is likely the result of the higher maternal glucose levels, reflected by higher HbA 1c values in the third trimester than in the controls, but effects of early hyperglycemia cannot be ruled out (24). Interestingly, despite neonatal hyperinsulinemia in the T1DM neonates, their birthweight was not different from control neonates. However, the shorter stature in T1DM neonates, which is another important and unexpected finding, may be associated with reduced lean mass. Thus, T1DM appears to affect the lean and fat compartments
6 doi: /jc Table 2. Concentration of Total, SFA, MUFA, and PUFA and Percent of FAs (micrograms per 100 mg FAs) in Maternal and Umbilical Vein and Artery Blood (Continued) Umbilical Vein Umbilical Artery T1DM (n = 30) Control (n = 30) P T1DM (n = 30) Control (n = 30) P ( ) a,c ( ) b,d < ( ) c ( ) d ( ) e,g ( ) f,h ( ) g ( ) h ( ) i,k 44.3 ( ) j,l ( ) k 44.0 ( ) l < ( ) m,o ( ) n,p ( ) o ( ) p ( ) q,s 19.9 ( ) r,t ( ) s 30.7 ( ) t ( ) u,w ( ) v,x ( ) w 186,1 ( ) x ( ) y,aa 31.4 ( ) z,bb ( ) aa 28.8 ( ) bb Data presented are median and first and third quartiles. The Mann-Whitney U test was used to test significant differences between the two groups. Wilcoxon signed-rank test (see footnotes). P values in bold are significant. Abbreviations: MUFAs, monounsaturated FAs; SFAs, saturated FAs. a Maternal and umbilical vein serum concentration of total FAs in T1DM, P, b Maternal and umbilical vein serum concentration of total FAs in control, P, c Umbilical vein and umbilical artery serum concentration of total FAs in T1DM, P, d Umbilical vein and umbilical artery serum concentration of total FAs in control, P = e Maternal and umbilical vein serum concentration of SFAs in T1DM, P, f Maternal and umbilical vein serum concentration of SFAs in control, P, g Umbilical vein and umbilical artery serum concentration of SFAs in T1DM, P, h Umbilical vein and umbilical artery serum concentration of SFAs in control, P = i Maternal and umbilical vein serum percentage of SFAs in T1DM, P = j Maternal and umbilical vein serum percentage of SFAs in control, P = k Umbilical vein and umbilical artery percentage of SFAs in T1DM, P = l Umbilical vein and umbilical artery percentage of SFAs in control, P = m Maternal and umbilical vein serum concentration of MUFAs in T1DM, P, 0.001). n Maternal and umbilical vein serum concentration of MUFAs in control, P, o Umbilical vein and umbilical artery serum concentration of MUFAs in T1DM, P, p Umbilical vein and umbilical artery serum concentration of MUFAs in control, P = q Maternal and umbilical vein serum percentage of MUFAs in T1DM, P, r Maternal and umbilical vein serum percentage of MUFAs in control, P, s Umbilical vein and umbilical artery percentage of MUFAs in T1DM, P = t Umbilical vein and umbilical artery serum percentage of MUFAs in control, P = u Maternal and umbilical vein serum concentration of PUFAs in T1DM, P, v Maternal and umbilical vein serum concentration of PUFAs in control, P, w Umbilical vein and umbilical artery serum concentration of PUFAs in T1DM, P, x Umbilical vein and umbilical artery serum concentration of PUFAs in control, P, y Maternal and umbilical vein serum percentage of PUFAs in T1DM, P, z Maternal and umbilical vein serum percentage of PUFAs in control, P, aa Umbilical vein and umbilical artery serum percentage of PUFAs in T1DM, P = bb Umbilical vein and umbilical artery serum percentage of PUFAs in control, P = disproportionally, although this must be verified by more direct measurements of body composition. A shorter length of neonates born to mothers of diabetic pregnancies was already found in GDM (25). In that study, the interpretation was offered that fetal FAs, through the transcription factor peroxisome proliferator-activated receptor-g, may drive mesenchymal stem cell differentiation to a more adipogenic than osteoblastic phenotype. Whereas this is speculative, the elevated cord blood levels of FAs, found here in T1DM, may support this notion, which certainly warrants further studies. T1DM effect on neonatal FAs In well-controlled T1DM, maternal FA levels were higher than in controls, although this did not reach statistical significance for each species. This was accompanied by higher concentrations of total FAs, SFAs, MUFAs, and PUFAs in the neonate. Steady-state levels are determined by the following: transplacental
7 2626 Djelmis et al T1DM Alters Neonatal Fatty Acids J Clin Endocrinol Metab, July 2018, 103(7): Table 3. FA Profile in Maternal Vein Serum, Umbilical Vein, and Umbilical Artery Serum transfer, de novo synthesis out of glucose, uptake into tissue, and lipolysis. The study design does not allow for distinguishing among these possibilities. Our study confirmed earlier findings (4, 26) of correlations in total FA concentration between maternal Figure 1. Linear regression between total FAs in maternal and umbilical vein serum (r = 0.685; P, 0.001). Maternal Serum FAs, mg/ml T1DM (n = 30) Control (n = 30) P Myristic acid (C14:0) 41.8 ( ) 8.8 ( ) Pentadecanoic acid (C15:0) 7.4 ( ) 1.9 ( ) Palmitic acid (C16:0) ( ) ( ) Stearic acid (C18:0) ( ) 62.7 ( ) Palmitoleic acid (C16:1n-7) 48.9 ( ) 35.3 ( ) Oleic acid (C18:1n-9) ( ) ( ) Vaccenic acid (C18:1n-7) 6.7 ( ) 0.0 ( a-linoleic acid (C18:3n-3) 10.2 ( ) 4.4 ( ) Eicosapentanoic acid (C20:5n-3) 4.0 ( ) 0.3 ( ) DHA (C22:6n-3) ( ) 70.7 ( ) Linoleic acid (C18:3n-6) 12.9 ( ) 0.8 ( ) AA (C20:4n-6) ( ) ( ) AA:(DHA + EPA) 2.8 ( ) 2.4 ( ) Percent AA, mg/100 mg FA 5.8 ( ) 5.9 ( ) Percent DHA, mg/100 mg FA 2.0 ( ) 1.8 ( ) (Continued) and umbilical vein serum and extends this to mothers with T1DM. Essential FAs are important for normal fetal growth and development (27). Transplacental transport of DHA, eicosapentaenoic acid (EPA), and AA occurs in several steps, from cell transmembrane transport through intracellular transport modulated by protein carriers to further passage through the cell membrane toward the fetus (8, 28). In our previous study, we demonstrated that there was no difference in LC-PUFA n-3 percentage between T1DM and control groups of pregnant women and their fetuses (12), which is in line with the results presented here. Our results differ from an earlier study that found lower percentage of AA and DHA in neonates born to mothers with T1DM (29). Here, the levels of AA and DHA were higher in women with T1DM and significantly higher in their fetuses compared with their control counterparts (Table 3). The major difference between the two studies is that we measured FA percentage in serum, whereas the lower AA and DHA percentage was found in neonatal phospholipids. This would suggest that T1DM modifies the incorporation of AA and DHA into phospholipids. Whether DHA concentrations in cord blood serum or in the phospholipid fraction are more relevant for neonatal development
8 doi: /jc Table 3. FA Profile in Maternal Vein Serum, Umbilical Vein, and Umbilical Artery Serum (Continued) Umbilical Vein Umbilical Artery T1DM (n 5 30) Control (n 5 30) P T1DM (n 5 30) Control (n 5 30) P 8.8 ( ) 2.2 ( ) ( ) 4.2 ( ) ( ) 0.5 ( ) ( ) 1.0 ( ) ( ) ( ) ( ) ( ) ( ) 36.7 ( ) ( ) ( ) ( ) 8.1 ( ) ( ) 28.6 ( ) ( ) 65.9 ( ) < ( ) ( ) < ( ) 0.0 ( ) ( ) 12.8 ( ) ( ) 0.0 ( ) ND 0.0 ( ) 0.0 ( ) ND 0.2 ( ) 0.0 ( ) NA 0.0 ( ) 0.0 ( ) NA 45.9 ( ) 19.9 ( ) ( ) 36.2 ( ) ( ) 0.3 ( ) < ( ) 1.1 ( ) ( ) 59.2 ( ) < ( ) ( ) ( ) 4.0 ( ) ( ) 3.7 ( ) ( ) 12.8 ( ) ( ) 13.5 ( ) ( ) 3.1 ( ) ( ) 3.4 ( ) Data presented are median and first and third quartiles. Mann-Whitney U test was used to test statistical difference between two groups. P values in bold are significant. Abbreviations: EPA, eicosapentaenoic acid; NA, not available; ND, not detected. remains to be established, but it is pertinent that the brain DHA transporter major facilitator superfamily domaincontaining protein 2 transfers DHA in phospholipids across the blood brain barrier (30). The placenta is important for selective AA and DHA canalization from the mother to the fetus; the evidence is a high coefficient of correlation between AA and DHA in the maternal and the umbilical vein blood (Fig. 2). The median maternal percent of AA (5.8%) and DHA (2.0%) in serum of mothers with T1DM was similar to the control group (AA, 5.9%; DHA, 1.8%). AA serves as a precursor of proinflammatory eicosanoids, whereas Table 4. Significant Spearman Correlations Between Umbilical Vein and Umbilical Artery Serum Total FAs and Among Neonatal Ponderal Index, Glucose, C-Peptide, Leptin, HbA 1c,andInsulin Resistance (HOMA2) Correlations rs P Glucose concentration between maternal 0.763,0.001 and umbilical vein Ponderal index and insulin resistance (HOMA2) C-Peptide and total FAs in umbilical vein Leptin and ponderal index Total FAs between umbilical artery and 0.883,0.001 umbilical vein AA and DHA in umbilical vein 0.513,0.001 C-Peptide and total FAs in umbilical artery Insulin resistance (HOMA2) and total FAs in umbilical artery Leptin and C-peptide in umbilical vein serum All P values are significant. DHA is a precursor of anti-inflammatory resolvins and protectins (31); this could suggest a proinflammatory environment in T1DM neonates that is perhaps associated with hyperleptinemia. In a recent randomized controlled trial, we found that DHA supplementation stimulated the production of endogenous insulin in women with T1DM and was accompanied by lower C-peptide levels in the newborn (32). In our study, neonates born by mothers with T1DM had an elevated AA/DHA + EPA ratio (median 4.1:1). This imbalance may be an indication of their increased risk to develop obesity later in life (33). It may well be that a beneficial effect of DHA supplementation may lie in improving the neonatal glucose-insulin axis and perhaps indirectly also, in DHA uptake into the brain across the blood brain barrier. This may also indirectly decrease the risk for childhood obesity. Strengths of the study This study investigates FA profiles and FA concentration in T1DM in arterial and venous cord blood. We have combined the FA measurements with those of key hormones known to influence lipid and FA levels, i.e., insulin and leptin. Cord blood was obtained with the placenta still in situ and the neonate not separated, reducing the influences of the postpartum period and allowing the results to represent the in vivo situation as closely as possible. As all women delivered by elective CS and were denied access to food, the levels of FAs and other parameters measured in umbilical serum were not influenced by mode of delivery or nutritional status of
9 2628 Djelmis et al T1DM Alters Neonatal Fatty Acids J Clin Endocrinol Metab, July 2018, 103(7): Figure 2. Linear regression between DHA and AA in umbilical vein serum (r = 0.924; P, 0.001). the women. The measurement of the arterial and venous cord blood is another strength. There has been only one study in GDM that also determined the FA profile in both arms of the umbilical circulation (34). The combination of these measurements with concentrations of hormonal regulators in the umbilical cord allows conclusions about potential mechanisms that determine the neonatal FA profile, although these must be confirmed in larger studies and other populations. We must acknowledge some limitations: The small sample size precluded significance of higher maternal FA levels in mothers with T1DM. The study included only well-controlled women with T1DM. The results may be different, especially for neonatal outcomes, in poorly controlled T1DM or in women without residual b-cell function, because adaptive and protective placental mechanisms may become exhausted under more extreme metabolic conditions (35). Future studies should measure DHA levels in serum, as well as in the phospholipids of newborn cord blood, and test which of these two fractions is more important for brain development and cognitive function in the children born to T1DM pregnancies. Conclusion In conclusion, the levels of leptin, C-peptide, insulin resistance, total FAs, SFAs, MUFAs, PUFAs, DHA, and AA were significantly higher in T1DM umbilical vein serum compared with those in the control group. Acknowledgments Financial Support: The study was part of the scientific project approved by the Ministry of Science, Education and Technology of the Republic of Croatia, entitled Metabolic and Endocrine Changes in Pregnant Patients with Diabetes (No ). Author Contributions: J.D. designed the study, developed the statistical analysis plan, wrote the manuscript, is the guarantor of this work, and takes responsibility for the integrity of the data and the accuracy of the data analysis. M.I., S.O., and D.S. collected data. E.B. extracted lipids and determined the fattyacidprofilebygaschromatography-mass spectrometry. G.D. and M.v.P. reviewed and edited the manuscript and contributed to the discussion. Correspondence and Reprint Requests: Josip Djelmis, MD, Clinical Department of Obstetrics and Gynecology, Zagreb University Hospital Center, Petrova 13, HR Zagreb, Croatia. josip. djelmis@zg.t-com.hr. Disclosure Summary: The authors have nothing to disclose. References 1. Atkinson MA, Eisenbarth GS. Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet. 2001;358(9277): Herrera E. Metabolic changes in diabetic pregnancy. In: Djelmis J, Desoye G, Ivanisevic M, eds. Diabetology of Pregnancy. Basel: Karger; 2005: Campbell FM, Taffesse S, Gordon MJ. Dutta-Roy AK. Plasma membrane fatty-acid-binding protein in human placenta: identification and characterization. Biochem Biophys Res Commun. 1995; 209(3): Hendrickse W, Stammers JP, Hull D. The transfer of free fatty acids across the human placenta. Br J Obstet Gynaecol. 1985;92(9): Desoye G, Gauster M, Wadsack C. Placental transport in pregnancy pathologies. Am J Clin Nutr. 2011;94(Suppl 6): 1896S 1902S. 6. Herrera E, Desoye G. Maternal and fetal lipid metabolism under normal and gestational diabetic conditions. Horm Mol Biol Clin Investig. 2016;26(2): Catalano PM, Thomas A, Huston-Presley L, Amini SB. Increased fetal adiposity: a very sensitive marker of abnormal in utero development. Am J Obstet Gynecol. 2003;189(6):
10 doi: /jc Hanebutt FL, Demmelmair H, Schiessl B, Larqué E, Koletzko B. Long-chain polyunsaturated fatty acid (LC-PUFA) transfer across the placenta. Clin Nutr. 2008;27(5): Neuringer M, Reisbick S, Janowsky J. The role of n-3 fatty acids in visual and cognitive development: current evidence and methods of assessment. J Pediatr. 1994;125(5):S39 S Zornoza-Moreno M, Fuentes-Hernández S, Carrión V, Alcántara- López MV, Madrid JA, López-Soler C, Sánchez-Solís M, Larqué E. Is low docosahexaenoic acid associated with disturbed rhythms and neurodevelopment in offsprings of diabetic mothers? Eur J Clin Nutr. 2014;68(8): Larqué E, Demmelmair H, Berger B, Hasbargen U, Koletzko B. In vivo investigation of the placental transfer of (13)C-labeled fatty acids in humans. J Lipid Res. 2003;44(1): Berberovic E, Ivanisevic M, Juras J, Horvaticek M, Delas I, Djelmis J. Arachidonic and docosahexaenoic acid in the blood of a mother and umbilical vein in diabetic pregnant women. J Matern Fetal Neonatal Med. 2013;26(13): Kolcić I, Polašek O, Pfeifer D, Smolej-Narancić N, Ilijić M,Bljajić D, Biloglav Z, Ivanisević M, Delmis J. Birth weight of healthy newborns in Zagreb area, Croatia. Coll Antropol. 2005;29(1): International Association of Diabetes and Pregnancy Study Groups Consensus Panel, Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, Damm P, Dyer AR, Leiva A, Hod M, Kitzmiler JL, Lowe LP, McIntyre HD, Oats JJ, Omori Y, Schmidt MI. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010;33(3): Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957;226(1): Levy JC, Matthews DR, Hermans MP. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care. 1998;21(12): Stock SM, Bremme KA. Elevation of plasma leptin levels during pregnancy in normal and diabetic women. Metabolism. 1998; 47(7): Schaefer-Graf UM, Meitzner K, Ortega-Senovilla H, Graf K, Vetter K, Abou-Dakn M, Herrera E. Differences in the implications of maternal lipids on fetal metabolism and growth between gestational diabetes mellitus and control pregnancies. Diabet Med. 2011;28(9): Nielsen LR, Rehfeld JF, Pedersen-Bjergaard U, Damm P, Mathiesen ER. Pregnancy-induced rise in serum C-peptide concentrations in women with type 1 diabetes. Diabetes Care. 2009;32(6): Maffei M, Volpe L, Di Cianni G, Bertacca A, Ferdeghini M, Murru S, Teti G, Casadidio I, Cecchetti P, Navalesi R, Benzi L. Plasma leptin levels in newborns from normal and diabetic mothers. Horm Metab Res. 1998;30(9): Linnemann K, Malek A, Sager R, Blum WF, Schneider H, Fusch C. Leptin production and release in the dually in vitro perfused human placenta. J Clin Endocrinol Metab. 2000;85(11): Wolf HJ, Ebenbichler CF, Huter O, Bodner J, Lechleitner M, Föger B, Patsch JR, Desoye G. Fetal leptin and insulin levels only correlate inlarge-for-gestational age infants. Eur J Endocrinol. 2000;142(6): Persson B, Westgren M, Celsi G, Nord E, Ortqvist E. Leptin concentrations in cord blood in normal newborn infants and offspring of diabetic mothers. Horm Metab Res. 1999;31(8): Desoye G, Nolan CJ. The fetal glucose steal: an underappreciated phenomenon in diabetic pregnancy. Diabetologia. 2016;59(6): Lampl M, Jeanty P. Exposure to maternal diabetes is associated with altered fetal growth patterns: A hypothesis regarding metabolic allocation to growth under hyperglycemic-hypoxemic conditions. Am J Hum Biol. 2004;16(3): Wolfe MD, Chuang LT, Rayburn WF, Wen PC, VanderJagt DJ, Glew RH. Low fatty acid concentrations in neonatal cord serum correlate with maternal serum. J Matern Fetal Neonatal Med. 2012;25(8): Innis SM. Essential fatty acids in growth and development. Prog Lipid Res. 1991;30(1): Campbell FM, Dutta-Roy AK. Plasma membrane fatty acidbinding protein (FABPpm) is exclusively located in the maternal facing membranes of the human placenta. FEBS Lett. 1995;375(3): Ghebremeskel K, Thomas B, Lowy C, Min Y, Crawford MA. Type 1 diabetes compromises plasma arachidonic and docosahexaenoic acids in newborn babies. Lipids. 2004;39(4): Nguyen LN, Ma D, Shui G, Wong P, Cazenave-Gassiot A, Zhang X, Wenk MR, Goh EL, Silver DL. Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid. Nature. 2014; 509(7501): Serhan CN, Chiang N, Dalli J, Levy BD. Lipid mediators in the resolution of inflammation. Cold Spring Harb Perspect Biol. 2014; 7(2):a Horvaticek M, Djelmis J, Ivanisevic M, Oreskovic S, Herman M. Effect of eicosapentaenoic acid and docosahexaenoic acid supplementation on C-peptide preservation in pregnant women with type-1 diabetes: randomized placebo controlled clinical trial. Eur J Clin Nutr. 2017;71(8): Simopoulos AP. An increase in the omega-6/omega-3 fatty acid ratio increases the risk for obesity. Nutrients. 2016;8(3): Ortega-Senovilla H, Alvino G, Taricco E, Cetin I, Herrera E. Gestational diabetes mellitus upsets the proportion of fatty acids in umbilical arterial but not venous plasma. Diabetes Care. 2009; 32(1): Gauster M, Hiden U, van Poppel M, Frank S, Wadsack C, Hauguel-de Mouzon S, Desoye G. Dysregulation of placental endothelial lipase in obese women with gestational diabetes mellitus. Diabetes. 2011;60(10):
MATERNAL GESTATIONAL DIABETES MELLITUS AND PLACENTAL LIPIDS
Note: for non-commercial purposes only MATERNAL GESTATIONAL DIABETES MELLITUS AND PLACENTAL LIPIDS Olaf Uhl 2 1, 1 0, Log10(p-value) 0-0, -1-1, -2-2, LPC160 PC160-160 PC160-181 PC160-203 PC160-226 PC180-181
More informationPlacental Transport in Pathologic Pregnancies
Note: for non-commercial purposes only Placental Transport in Pathologic Pregnancies Gernot Desoye Clinic of Obstetrics and Gynaecology Medical University, Graz Most Common Pregnancy Pathologies Diabetes
More informationPlacental Transport and Metabolism in Fetal Overgrowth A Workshop Report
Placenta (2006), Vol. 27, Supplement A, Trophoblast Research, Vol. 20 doi:10.1016/j.placenta.2006.01.017 Placental Transport and Metabolism in Fetal Overgrowth A Workshop Report T. Jansson a,d, *, I. Cetin
More informationOver the last 2 decades, the incidence of obesity in reproductive-age women
Catalano Impact of Maternal GDM and Obesity on Mother and Fetus Patrick Catalano, MD Over the last 2 decades, the incidence of obesity in reproductive-age women has increased significantly. The increase
More informationRole of DHA in Early Life Nutrition in the First 1000 days
Role of DHA in Early Life Nutrition in the First 1000 days Role of DHA in Early Life Nutrition in the First 1000 days Professor Barbara School of Medicine, University of Wollongong, NSW, Australia Docosahexaenoic
More informationThe effect of FADS genotypes, fatty acids, and fish intake on mental development in children
The effect of FADS genotypes, fatty acids, and fish intake on mental development in children Results from the ALSPAC study Eva Lattka Colin D Steer, Pauline M Emmett, Norman Klopp, Thomas Illig and Berthold
More informationSkeletal muscle metabolism was studied by measuring arterio-venous concentration differences
Supplemental Data Dual stable-isotope experiment Skeletal muscle metabolism was studied by measuring arterio-venous concentration differences across the forearm, adjusted for forearm blood flow (FBF) (1).
More informationBREAST MILK COMPONENTS AND POTENTIAL INFLUENCE ON GROWTH
Note: for non-commercial purposes only CAMPUS GROSSHADERN CAMPUS INNENSTADT BREAST MILK COMPONENTS AND POTENTIAL INFLUENCE ON GROWTH Maria Grunewald, Hans Demmelmair, Berthold Koletzko AGENDA Breast Milk
More informationDiabetes in Pregnancy. L.Sekhavat MD
Diabetes in Pregnancy L.Sekhavat MD Diabetes in Pregnancy Gestational Diabetes Pre-gestational diabetes (overt) Insulin dependent (type1) Non-insulin dependent (type 2) Definition Gestational diabetes
More informationVishwanath Pattan Endocrinology Wyoming Medical Center
Vishwanath Pattan Endocrinology Wyoming Medical Center Disclosure Holdings in Tandem Non for this Training Introduction In the United States, 5 to 6 percent of pregnancies almost 250,000 women are affected
More informationGender-specific differences in essential fatty acid metabolism
Note: for non-commercial purposes only Gender-specific differences in essential fatty acid metabolism Tamás Decsi and Kathy Kennedy Department of Paediatrics, University of Pécs, Pécs, Hungary Nutrition
More informationTheme 6 / Infant of Diabetic Mother and Long-Term Consequences
Theme 6 / Infant of Diabetic Mother and Long-Term Consequences PP 43 Disproportionate body composition and neonatal outcome in offspring of mothers with and without gestational diabetes Persson M 1, Fadl
More informationGestational Diabetes. Gestational Diabetes:
Gestational Diabetes Detection and Management Steven Gabbe, MD The Ohio State University Medical Center Gestational Diabetes: Detection and Management Learning Objectives: At the conclusion of this presentation,
More informationPregnancy outcomes in Korean women with diabetes
Pregnancy outcomes in Korean women with diabetes Sung-Hoon Kim Department of Medicine, Cheil General Hospital & Women s Healthcare Center, Dankook University College of Medicine, Seoul, Korea Conflict
More informationCOMPLICATIONS OF PRE-GESTATIONAL AND GESTATIONAL DIABETES IN SAUDI WOMEN: ANALYSIS FROM RIYADH MOTHER AND BABY COHORT STUDY (RAHMA)
COMPLICATIONS OF PRE-GESTATIONAL AND GESTATIONAL DIABETES IN SAUDI WOMEN: ANALYSIS FROM RIYADH MOTHER AND BABY COHORT STUDY (RAHMA) Prof. Hayfaa Wahabi, King Saud University, Riyadh Saudi Arabia Hayfaa
More informationDiabetes: The Effects of Maternal Diabetes on Fetal Development and Outcomes Sherrie McElvy, MD May 18, 2016
Diabetes: The Effects of Maternal Diabetes on Fetal Development and Outcomes Sherrie McElvy, MD May 18, 2016 Medical Director Sweet Success Sutter Medical Center Sacramento Perinatal Associates of Sacramento
More informationMETABOLIC SYNDROME IN REPRODUCTIVE FEMALES
METABOLIC SYNDROME IN REPRODUCTIVE FEMALES John J. Orris, D.O., M.B.A Division Head, Reproductive Endocrinology & Infertility, Main Line Health System Associate Professor, Drexel University College of
More informationADVERSE PREGNANCY OUTCOMES IN GESTATIONAL DIABETES MELLITUS - STUDY IN AN APEX HOSPITAL
ADVERSE PREGNANCY OUTCOMES IN GESTATIONAL DIABETES MELLITUS - STUDY IN AN APEX HOSPITAL *Anuradha Ghosh 1 and Sudip Kumar Saha 2 1 Department of Gynecology and Obstetrics, Sagar Dutta Medical College and
More informationPolyunsaturated fatty acids in maternal plasma and in breast milk
Polyunsaturated fatty acids in maternal plasma and in breast milk F. Marangoni, 1 C. Agostoni, 2 A. M. Lammardo, 2 M. Bonvissuto, 2 M. Giovannini, 2 C. Galli, 1 E. Riva 2 1 Department of Pharmacological
More informationEffect of pregnancy on insulin requirements differs between type 1 and type 2 diabetes: A cohort study of 222 pregnancies
Australian and New Zealand Journal of Obstetrics and Gynaecology 2016; 56: 352 357 DOI: 10.1111/ajo.12446 Original Article Effect of pregnancy on insulin requirements differs between type 1 and type 2
More informationMATERNAL FETAL FEATURES
LIPIDOLOGY IN PEDIATRICS 2015 MATERNAL FETAL FEATURES Ornella Guardamagna, MD Department of Health Science and Pediatrics, Turin University MAIN STEPS 1. Cholesterol and fatty acids relevance to the fetus
More informationPlacental transfer of essential fatty acids in humans: Venous-arterial difference for docosahexaenoic acid in fetal umbilical erythrocytes
Proc. Natl. Acad. Sci. USA Vol. 87, pp. 7902-7906, October 1990 Medical Sciences Placental transfer of essential fatty acids in humans: Venous-arterial difference for docosahexaenoic acid in fetal umbilical
More informationTHE FIRST NINE MONTHS AND CHILDHOOD OBESITY. Deborah A Lawlor MRC Integrative Epidemiology Unit
THE FIRST NINE MONTHS AND CHILDHOOD OBESITY Deborah A Lawlor MRC Integrative Epidemiology Unit d.a.lawlor@bristol.ac.uk Sample size (N of children)
More informationC-Reactive Protein Levels in Non-Obese Pregnant Women with Gestational Diabetes
Tohoku J. Exp. Med., 2005, 206, 341-345 CRP and GDM 341 C-Reactive Protein Levels in Non-Obese Pregnant Women with Gestational Diabetes SİMİN ROTA, BAŞAK YILDIRIM, 1 BABÜR KALELİ, 1 HÜLYA AYBEK, KORAY
More informationThe Relationship Between Maternal Dietary Fat Intake, Glucose Control, and infant Birth Weight
Oregon Health & Science University OHSU Digital Commons Scholar Archive 5-2014 The Relationship Between Maternal Dietary Fat Intake, Glucose Control, and infant Birth Weight Lucille Harrison Glaize Follow
More informationFatty acids, cardiovascular disease and diabetes
Fatty acids, cardiovascular disease and diabetes Rajiv Chowdhury, Nita Forouhi 28 th October 2015 Workshop on nutritional biomarkers A joint PHRI/MRC Epidemiology Unit Initiative Population nutrient goal
More informationMetabolic Programming. Mary ET Boyle, Ph. D. Department of Cognitive Science UCSD
Metabolic Programming Mary ET Boyle, Ph. D. Department of Cognitive Science UCSD nutritional stress/stimuli organogenesis of target tissues early period critical window consequence of stress/stimuli are
More informationCarlo Agostoni Fondazione IRCCS Department of Maternal and Pediatric Sciences University of Milan, Italy
Carlo Agostoni Fondazione IRCCS Department of Maternal and Pediatric Sciences University of Milan, Italy Energy Protein Fat quality docosahexaenoic acid Micronutrients Vitamin D Dieting during lactation?
More informationFacts on Fats. Ronald P. Mensink
Facts on Fats Ronald P. Mensink Department of Human Biology NUTRIM, School for Nutrition, Toxicology and Metabolism Maastricht University Maastricht The Netherlands Outline of the Presentation Saturated
More informationCurrent Trends in Diagnosis and Management of Gestational Diabetes
Current Trends in Diagnosis and Management of Gestational Diabetes Shreela Mishra, MD Assistant Clinical Professor UCSF Fresno Medical Education Program 2/2/2019 Disclosures No disclosures 2/2/19 Objectives
More informationManagement of Pregestational and Gestational Diabetes Mellitus
Background and Prevalence Management of Pregestational and Gestational Diabetes Mellitus Pregestational Diabetes - 8 million women in the US are affected, complicating 1% of all pregnancies. Type II is
More informationPregnancies complicated by diabetes. Marina Mickleson Nurse Practitioner Midwife CDE
Pregnancies complicated by diabetes Marina Mickleson Nurse Practitioner Midwife CDE Two types Pre gestational Gestational diabetes Both types are on the increase Pre conception work up is imperative for
More informationFatty acids and cardiovascular health: current evidence and next steps
Fatty acids and cardiovascular health: current evidence and next steps Emanuele Di Angelantonio, MD, PhD Department of Public Health and Primary Care NICE guidelines on fatty acids Eliminate the use of
More informationGestational Diabetes Mellitus Causes Changes in the Concentrations of Adipocyte Fatty Acid Binding Protein and Other Adipocytokines in Cord Blood
Pathophysiology/Complications O R I G I N A L A R T I C L E Gestational Diabetes Mellitus Causes Changes in the Concentrations of Adipocyte Fatty Acid Binding Protein and Other Adipocytokines in Cord Blood
More informationEvaluation of first trimester fasting blood glucose as a predictor of gestational diabetes mellitus
Original Research Article DOI: 10.18231/2394-2754.2017.0014 Evaluation of first trimester fasting blood glucose as a predictor of gestational diabetes mellitus Reshma Shri Aravind 1,*, Latha Maheshwari
More informationDietary Fatty Acids and the Risk of Hypertension in Middle-Aged and Older Women
07/14/2010 Dietary Fatty Acids and the Risk of Hypertension in Middle-Aged and Older Women First Author: Wang Short Title: Dietary Fatty Acids and Hypertension Risk in Women Lu Wang, MD, PhD, 1 JoAnn E.
More informationFOOD-CT FOOD-CT EARNEST
FOOD-CT-2005-007036 EARNEST EARly Nutrition programming- long term follow up of Efficacy and Safety Trials and integrated epidemiological, genetic, animal, consumer and economic research Instrument: Thematic
More informationPre-pregnancy body mass index and the risk of adverse outcome in type 1 diabetic pregnancies: a population-based cohort study
Open Access To cite: Persson M, Pasupathy D, Hanson U, et al. Pre-pregnancy body mass index and the risk of adverse outcome in type 1 diabetic pregnancies: a population-based cohort study. BMJ Open 2012;2:
More informationGestational Diabetes: Long Term Metabolic Consequences. Outline 5/27/2014
Gestational Diabetes: Long Term Metabolic Consequences Gladys (Sandy) Ramos, MD Associate Clinical Professor Maternal Fetal Medicine Outline Population rates of obesity and T2DM Obesity and metabolic syndrome
More informationGestational Diabetes in Rural Antenatal Clinics:
Gestational Diabetes in Rural Antenatal Clinics: How do we compare? Cook SJ 1,2, Phelps L 1, Kwan M 2 Darling Downs Health and Hospital Service University of Queensland Rural Clinical School Gestational
More informationWhat Degree of Maternal Metabolic Control in Women With Type 1 Diabetes Is Associated With Normal Body Size and Proportions in Full-Term Infants?
Clinical Care/Education/Nutrition O R I G I N A L A R T I C L E What Degree of Maternal Metabolic Control in Women With Type 1 Diabetes Is Associated With Normal Body Size and Proportions in Full-Term
More informationThe Role of LCPUFA in Obesity. M.Tom Clandinin. The Alberta Institute for Human Nutrition The University of Alberta Edmonton, Alberta, Canada
The Role of LCPUFA in Obesity by M.Tom Clandinin The Alberta Institute for Human Nutrition The University of Alberta Edmonton, Alberta, Canada How big is the Conceptual Problem? Some assumptions: 150lb
More informationDo pigs benefit from omega-3 fatty acids?
Do pigs benefit from omega-3 fatty acids? Denise Beaulieu Assistant Professor Animal & Poultry Science Introduction What are omega-3 fatty acids? Outline Why would we consider augmenting the diet of growing
More informationMaternal and Infant Nutrition Briefs
Maternal and Infant Nutrition Briefs A research-based newsletter prepared by the University of California for professionals interested in maternal and infant nutrition March/April 2003 New Guidelines on
More informationSeafood consumption, the DHA content of mothers' milk and prevalence rates of postpartum depression: a cross-national, ecological analysis
Seafood consumption, the DHA content of mothers' milk and prevalence rates of postpartum depression: a cross-national, ecological analysis 1 Journal of Affective Disorders: Volume 69, Issues 1-3, May 2002,
More informationThe New GDM Screening Guidelines. Jennifer Klinke MD, FRCPC Endocrinologist and Co director RCH Diabetes in Pregnancy Program
The New GDM Screening Guidelines Jennifer Klinke MD, FRCPC Endocrinologist and Co director RCH Diabetes in Pregnancy Program Disclosures Current participant (RCH site) for MiTy study Metformin in women
More information2018 Standard of Medical Care Diabetes and Pregnancy
2018 Standard of Medical Care Diabetes and Pregnancy 2018 Standard of Medical Care Diabetes and Pregnancy Marjorie Cypress does not have any relevant financial relationships with any commercial interests
More informationFetal growth patterns in fetuses of women with pregestational diabetes mellitus
Ultrasound Obstet Gynecol 2006; 28: 934 938 Published online 3 November 2006 in Wiley InterScience (www.interscience.wiley.com). DOI: 10.1002/uog.3831 Fetal growth patterns in fetuses of women with pregestational
More informationOral glucose lowering agents in gestational diabetes. Yes: E. Sobngwi (Cameroon) No: A. Vambergue (France)
Oral glucose lowering agents in gestational diabetes Yes: E. Sobngwi (Cameroon) No: A. Vambergue (France) CONTROVERSIES Oral glucose lowering agents in gestational diabetes «NO» Pr Anne VAMBERGUE Department
More informationDiabetes Care 33: , 2010
Pathophysiology/Complications O R I G I N A L A R T I C L E Differences in Maternal Circulating Fatty Acid Composition and Dietary Fat Intake in Women With Gestational Diabetes Mellitus or Mild Gestational
More informationDiabetes in Pregnancy: The Risks For Two Patients
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/the-connect-dialogues/diabetes-in-pregnancy-the-risks-for-twopatients/1793/
More informationNote: for non-commercial purposes only. Fatty acid composition in blood and obesity in childhood. Marie Standl
Note: for non-commercial purposes only Fatty acid composition in blood and obesity in childhood Marie Standl Helmholtz Zentrum München Institute of Epidemiology I Munich, 13/03/14 Background Genetic and
More informationOPINION. of the French Food Safety Agency on the update of French population reference intakes (ANCs) for fatty acids. Maisons-Alfort, 1 March 2010
Maisons-Alfort, 1 March 2010 OPINION THE DIRECTOR GENERAL of the French Food Safety Agency on the update of French population reference intakes (ANCs) for fatty s 1. REVIEW OF THE REQUEST The French Food
More informationMaternal and Fetal Complications in Diabetes Pregnancy
Maternal and Fetal Complications in Diabetes Pregnancy Helen R Murphy Professor of Medicine (Diabetes & Antenatal Care), UEA Professor of Women s Health, Kings College London hm386@medschl.cam.ac.uk 1
More informationCHAPTER 28 LIPIDS SOLUTIONS TO REVIEW QUESTIONS
28 09/16/2013 17:44:40 Page 415 APTER 28 LIPIDS SLUTINS T REVIEW QUESTINS 1. The lipids, which are dissimilar substances, are arbitrarily classified as a group on the basis of their solubility in fat solvents
More informationProfessor, of Human Nutrition
ω-3 fatty acids: The Effects during Pregnancy and Breast feeding Antonis Zampelas Professor, of Human Nutrition Director, Laboratory of Food Chemistry and Human Nutrition, Department of Food Science and
More informationPostpartum Diabetes Screening: adherence rate and the performance of fasting plasma glucose versus oral glucose tolerance test
Diabetes Care Publish Ahead of Print, published online September 9, 2009 adherence of postpartum diabetes screening Postpartum Diabetes Screening: adherence rate and the performance of fasting plasma glucose
More information2011, Editrice Kurtis
J. Endocrinol. Invest. : -, 2011 DOI: 10.2/902 The role of visfatin in the pathogenesis of gestational diabetes mellitus D.E. Gok 1, M. Yazici 1, G. Uckaya 1, S.E. Bolu 1, Y. Basaran 2, T. Ozgurtas, S.
More informationReminder: NPIC/QAS CME/CEU Program
V.12.2 Special Report: Perinatal Complications associated with Gestational and Pregestational Diabetes I. Introduction Diabetes mellitus is a metabolic disease characterized by chronic hyperglycemia and
More informationGestational Diabetes Mellitus Dr. Fawaz Amin Saad
Gestational Diabetes Mellitus Dr. Fawaz Amin Saad Senior Consultant OB/GYN, Al-Hayat Medical Center, Doha, Qatar DISCLOSURE OF CONFLICT OF INTEREST I am a full-time Employee at Al-Hayat Medical Center.
More informationCHAPTER 28 LIPIDS SOLUTIONS TO REVIEW QUESTIONS
HAPTER 28 LIPIDS SLUTINS T REVIEW QUESTINS 1. The lipids, which are dissimilar substances, are arbitrarily classified as a group on the basis of their solubility in fat solvents and their insolubility
More informationObjectives. Diabetes in Pregnancy: A Growing Dilemma. Diabetes in the US 10/6/2015. Disclosure. The presenter has no conflicts to disclose
Diabetes in Pregnancy: A Growing Dilemma Kathy O Connell, MN RN Perinatal Clinical Nurse Specialist University of Washington Medical Center Seattle, WA koconnll@uw.edu Objectives Describe pathophysiologic
More informationObjectives. Diabetes and Obesity in Pregnancy. In Diabetes. Diabetes in Pregnancy
Objectives Diabetes and Obesity in Pregnancy. Health Impact for the mother and child Bresta Miranda, MD Assistant Professor of Clinical Medicine University of Miami, Miller School of Medicine Review physiologic
More informationOBJECTIVE. Lipids are largely hydrocarbon derivatives and thus represent
Paper 4. Biomolecules and their interactions Module 20: Saturated and unsaturated fatty acids, Nomenclature of fatty acids and Essential and non-essential fatty acids OBJECTIVE The main aim of this module
More informationWhat is gestational diabetes?
ESPEN Congress Cannes 2003 Organised by the Israel Society for Clinical Nutrition Education and Clinical Practice Programme Session: Dietitian Symposium: Nutrition throughout the woman life cycle An Update
More informationEpidemiology and Prevention
Epidemiology and Prevention Associations of Pregnancy Complications With Calculated Cardiovascular Disease Risk and Cardiovascular Risk Factors in Middle Age The Avon Longitudinal Study of Parents and
More informationConsistent glucose measurement. Consistent outcome measurement
Appendix 3: Supplementary tables and forest plots [posted as supplied by author] Table A. Results of the risk of bias assessment Study Year of publication Prospective or retrospective Representative population
More informationEicosapentaenoic Acid and Docosahexaenoic Acid: Are They Different?
Eicosapentaenoic Acid and Docosahexaenoic Acid: Are They Different? Trevor A Mori, Ph.D., Professor, School of Medicine and Pharmacology, Royal Perth Hospital Unit, University of Western Australia, Perth,
More informationOriginal Article. Keiko KOHNO 1), Kazuhiko HOSHI 1), Motoi TAKIZAWA 1), Takashi KANEKO 2), and Shuji HIRATA 1)
Yamanashi Med. J. 21(3), 53 ~ 58, 2006 Original Article Usefulness of the 50-g Glucose Challenge Test for Screening of Patients with Gestational Diabetes Mellitus and an Analysis of the Timing of Administration
More informationMaternal and Fetal Outcomes in Diabetic Pregnant Women
Maternal and Fetal Outcomes in Diabetic Pregnant Women Muwafag Hyari MD*, Hala Abu-Romman MD**, Kamel Ajlouni MD* ABSTRACT Objective: To assess maternal and fetal outcomes in Jordanian women with known
More informationAdiponectin in mother-and-child couple: is there a relation with materno-foetal transfer of nutrients, obesity and risk of type 2 diabetes?
Adiponectin in mother-and-child couple: is there a relation with materno-foetal transfer of nutrients, obesity and risk of type 2 diabetes? Félix Ovono Abessolo 1, Jean Pierre Ngou-Mve-Ngou 2, John Mouba
More informationA Study of Gestational Diabetes in Patients in a Tertiary Care Hospital in Hyderabad Telangana State, India
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 6 Number 10 (2017) pp. 2586-2590 Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2017.610.304
More informationPregestational and Gestational Diabetes
Pregestational and Gestational Diabetes Francis S. Nuthalapaty, MD Greenville Health System University of South Carolina School of Medicine - Greenville Case History 30 year old black female presents to
More information39 th Annual Perinatal Conference Vanderbilt University December 6, 2013 IUGR. Diagnosis and Management
39 th Annual Perinatal Conference Vanderbilt University December 6, 2013 IUGR Diagnosis and Management Giancarlo Mari, M.D., M.B.A. Professor and Chair Department of Obstetrics and Gynecology University
More informationEarly life influences on adult chronic
Early life influences on adult chronic disease among aboriginal people Sandra Eades, Lina Gubhaju, Bridgette McNamara, Ibrahima Diouf, Catherine Chamberlain, Fiona Stanley University of Sydney October
More informationISSN X (Print) Original Research Article. DOI: /sjams *Corresponding author Sholeh Saeb
DOI: 10.21276/sjams.2017.5.3.23 Scholars Journal of Applied Medical Sciences (SJAMS) Sch. J. App. Med. Sci., 2017; 5(3B):805-815 Scholars Academic and Scientific Publisher (An International Publisher for
More informationIndia is one of the diabetes capitals of the world and at the same time the capital
Yajnik Undernutrition and Overnutrition During Pregnancy in India: C. S. Yajnik, MD, FRCP India is one of the diabetes capitals of the world and at the same time the capital for low birth weight (LBW)
More informationDietary Reference Values: a Tool for Public Health
HOGE GEZONDHEISRAAD Dietary Reference Values: a Tool for Public Health CONSEIL SUPERIEUR DE LA SANTE Belgian Dietary Reference Values for Energy and Macronutrients: FATS G. De Backer Brussels, February
More informationLIPID METABOLISM. Sri Widia A Jusman Department of Biochemistry & Molecular Biology FMUI
LIPID METABOLISM Sri Widia A Jusman Department of Biochemistry & Molecular Biology FMUI Lipid metabolism is concerned mainly with fatty acids cholesterol Source of fatty acids from dietary fat de novo
More informationEffect of maternal weight, adipokines, glucose intolerance and lipids on infant birth weight among women without gestational diabetes mellitus
CMAJ Research Effect of maternal weight, adipokines, glucose intolerance and lipids on infant birth weight among women without gestational diabetes mellitus Ravi Retnakaran MD, Chang Ye MSc, Anthony J.G.
More informationA high concentration of prorenin in early pregnancy is associated with development of pre-eclampsia in women with type 1 diabetes
Diabetologia (2011) 54:1615 1619 DOI 10.1007/s00125-011-2087-7 SHORT COMMUNICATION A high concentration of prorenin in early pregnancy is associated with development of pre-eclampsia in women with type
More informationANSC/NUTR) 618 LIPIDS & LIPID METABOLISM Dietary fat and Cardiovascular Disease
ANSC/NUTR) 618 LIPIDS & LIPID METABOLISM Dietary fat and Cardiovascular Disease I. Investigations in humans relating dietary fat intake to serum cholesterol A. Ansel Keys: the Keys Formula Cholesterol
More informationDiabetes: Definition Pathophysiology Treatment Goals. By Scott Magee, MD, FACE
Diabetes: Definition Pathophysiology Treatment Goals By Scott Magee, MD, FACE Disclosures No disclosures to report Definition of Diabetes Mellitus Diabetes Mellitus comprises a group of disorders characterized
More informationHAPO Study Rationale. Blinded Participants At Each Field Center
Clinical Implications of IADPSG Recommendations on the Diagnosis & Treatment of Gestational Diabetes Mellitus 36 th Annual Congress The Korean Diabetes Association Busan BEXCO, Korea October 16-17, 2010
More informationGestational Diabetes in Resouce. Prof Satyan Rajbhandari (RAJ)
Gestational Diabetes in Resouce Limited Area Prof Satyan Rajbhandari (RAJ) Case History RP, 26F Nepali girl settled in the UK Primi Gravida BMI: 23 FH of type 2 DM 75 gm Glucose OGTT in week 25 0 Min
More informationResearch Article Implementation of the International Association of Diabetes and Pregnancy Study Groups Criteria: Not Always a Cause for Concern
Hindawi Publishing Corporation Journal of Pregnancy Volume 2015, Article ID 754085, 5 pages http://dx.doi.org/10.1155/2015/754085 Research Article Implementation of the International Association of Diabetes
More informationDevelopmental Origins of Health and Disease
Developmental Origins of Health and Disease Roles of Maternal Nutrition Matthew W. Gillman, MD, SM Harvard University Thanks to Faculty, Trainees, & Staff Obesity Prevention Program Department of Population
More informationDIABETES WITH PREGNANCY
DIABETES WITH PREGNANCY Prof. Aasem Saif MD,MRCP(UK),FRCP (Edinburgh) Maternal and Fetal Risks Diabetes in pregnancy is associated with risks to the woman and to the developing fetus. Maternal and Fetal
More informationRapid Analysis of 37 FAMEs with the Agilent 8860 Gas Chromatograph
Application Note Food Rapid Analysis of 37 FAMEs with the Agilent 88 Gas Chromatograph Author Youjuan Zhang Agilent Technologies (Shanghai) Co. Ltd., Shanghai 131 P. R. China Abstract An Agilent 88 GC
More informationDiagnosis of gestational diabetes mellitus: comparison between National Diabetes Data Group and Carpenter Coustan criteria
Asian Biomedicine Vol. 8 No. 4 August 2014; 505-509 Brief communication (Original) DOI: 10.5372/1905-7415.0804.320 Diagnosis of gestational diabetes mellitus: comparison between National Diabetes Data
More informationKetonemia and ketonuria in gestational diabetes mellitus
HORMONES 2015, 14(4):644-650 Research paper Ketonemia and ketonuria in gestational diabetes mellitus Loukia Spanou, 1 Kalliopi Dalakleidi, 2 Konstantia Zarkogianni, 2 Anastasia Papadimitriou, 1 Konstantina
More information*This statement has not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any
*This statement has not been evaluated by the Food and Drug Administration. Healthy Fats. Essential for Health. Exceptional Quality. In a nutshell, these are the benefits of Solgar s extensive selection
More informationOriginal paper A.-S. MARYNS 1, I. DEHAENE 1, G. PAGE 2. Abstract
FACTS VIEWS VIS OBGYN, 2017, 9 (3): 133-140 Original paper Maternal and neonatal outcomes in a treated versus nontreated cohort of women with Gestational Diabetes Mellitus according to the HAPO 5 and 4
More information298 Biomed Environ Sci, 2015; 28(4):
298 Biomed Environ Sci, 2015; 28(4): 298-302 Letter to the Editor Effects of Maternal Linseed Oil Supplementation on Metabolic Parameters in Cafeteria Diet-induced Obese Rats * BENAISSA Nawel 1, MERZOUK
More informationDiabetes Care 34: , also been reported from other European countries (3). High BW in offspring of type 1 diabetic
Epidemiology/Health Services Research O R I G I N A L A R T I C L E Birth Size Distribution in 3,705 Infants Born to Mothers With Type 1 Diabetes A population-based study MARTINA PERSSON, MD 1 DHARMINTRA
More informationResearch: Epidemiology Overweight and obesity: a remaining problem in women treated for severe gestational diabetes
Research: Epidemiology Overweight and obesity: a remaining problem in women treated for severe gestational diabetes K. Hilden 1, U. Hanson 1,2, M. Persson 3 and H. Fadl 1 1 Department of Obstetrics and
More informationORIGINAL ARTICLE. Ying Zhang 1,2 *, Hao-hang Zhang 1,Jia-huiLu 1,Si-yuanzheng 1,TaoLong 1, Ying-tao Li 3,Wei-zhenWu 3, Fang Wang 3
Changes in serum adipocyte fatty acid-binding protein in women with gestational diabetes mellitus and normal pregnant women during mid- and late pregnancy Ying Zhang 1,2 *, Hao-hang Zhang 1,Jia-huiLu 1,Si-yuanzheng
More informationThe association between maternal insulin resistance in mid-pregnancy and neonatal birthweight in uncomplicated pregnancies
Endocrine Journal 2014, 61 (10), 1019-1024 Original The association between maternal insulin resistance in mid-pregnancy and neonatal birthweight in uncomplicated pregnancies Hiroshi Yamashita, Ichiro
More informationLike mother, like offspring Does maternal overweight predict health outcomes?
Like mother, like offspring Does maternal overweight predict health outcomes? Patricia Iozzo, MD, PhD Institute of Clinical Physiology National Research Council (CNR), Pisa, Italy Brussels 16 October 2017
More informationSystematic Review of Fatty Acid Composition of Human Milk from Mothers of Preterm Compared to Full-Term Infants
Original Paper DOI: 10.1159/000114209 Received: October 16, 2006 Accepted: July 19, 2007 Published online: January 28, 2008 Systematic Review of Fatty Acid Composition of Human Milk from Mothers of Preterm
More information